Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Anas, M Hanif"'
Autor:
admin pjmd, Anas M. Hanif, Ali Akbar Sial, Huma Ali, Farya Zafar, Anwar Ejaz Beg, Atta Ur- Rehman
Publikováno v:
Pakistan Journal of Medicine and Dentistry, Vol 8, Iss 2 (2024)
Pharmaceutical companies have introduced several drug delivery systems in the field of Pharmaceutical sciences that provide better and faster therapeutic response in patients to modulate pain and inflammation. In the present article a detail on fast
Externí odkaz:
https://doaj.org/article/a1f82bedd736439abf7d3e5963c50ad3
Autor:
Anas, M Hanif, Rabia, Bushra, Wajiha, Iffat, Sana, Ghayas, Shaheen, Perveen, Humayun, Riaz, Shazia, Alam, Syed Imran, Ali, Nahlah Elkudssiah, Ismail, Zeb-, Un-Nisa
Publikováno v:
Pakistan journal of pharmaceutical sciences. 34(4(Supplementary))
Empagliflozin is a selective inhibitor of sodium glucose co-transporter II, given as mono therapy or an add-on treatment to reduce the glycated hemoglobin levels in type 2 diabetes. This work deals with designing, formulating and optimizing empaglifl
Autor:
Anas, M Hanif, Rabia, Bushra, Nahlah Elkudssiah, Ismail, Rahila, Bano, Saima, Abedin, Shazia, Alam, Maqsood, Ahmed Khan, Hafiz, Muhammad Arif
Publikováno v:
Pakistan journal of pharmaceutical sciences. 34(3(Supplementary))
The current investigation is based on efficient method development for the quantification of empagliflozin in raw and pharmaceutical dosage forms, as no pharmacopoeial method for the drug is available so far. The developed analytical method was valid
Autor:
Anas M, Hanif, Ali Akbar, Sial, Huma, Ali, Farya, Zafar, Mirza Tasawar, Baig, Rabia, Bushra, Maqsood Ahmed, Khan, Amber, Nawab, Omer, Mustapha, Shumaila, Shafique
Publikováno v:
Pakistan journal of pharmaceutical sciences. 31(5(Supplementary))
Healthcare professionals including physicians and pharmacists have been trying since long to come across and work out regarding the issue of generic alternatives, which is highly affected by factors like therapeutic efficacy, cost effectiveness, aest